diphenhydramine has been researched along with Ischemic Stroke in 1 studies
Diphenhydramine: A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
diphenhydramine : An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
antitussive : An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.
Ischemic Stroke: Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Articles included in this review highlight acute agitation management, acute appendicitis treatment, sexually transmitted infection updates, optimizing sepsis management and treatment, updates for the ideal thrombolytic agent in acute ischemic stroke and endovascular therapy candidates, indications for tranexamic acid, calicium for out of hospital cardiac arrest, optimial inotrope for cardiogenic shock, awareness during rapid sequence intubation paralysis, comparison of propofol or dexmedetomidine for sedation, treatment of cannabis hyperemsis syndrome, and prophylactic use of diphenhydramine to reduce neuroleptic side effects." | 5.22 | The Emergency Medicine Pharmacotherapy Literature of 2021. ( Brown, CS; Faine, B; Flack, T; Gilbert, B; Howington, GT; Laub, J; Porter, B; Rech, MA; Sarangarm, P; Slocum, GW; Zepeski, A; Zimmerman, DE, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, CS | 1 |
| Sarangarm, P | 1 |
| Faine, B | 1 |
| Rech, MA | 1 |
| Flack, T | 1 |
| Gilbert, B | 1 |
| Howington, GT | 1 |
| Laub, J | 1 |
| Porter, B | 1 |
| Slocum, GW | 1 |
| Zepeski, A | 1 |
| Zimmerman, DE | 1 |
1 review available for diphenhydramine and Ischemic Stroke
| Article | Year |
|---|---|
The Emergency Medicine Pharmacotherapy Literature of 2021.
Topics: Antipsychotic Agents; Dexmedetomidine; Diphenhydramine; Emergency Medicine; Fibrinolytic Agents; Hum | 2022 |